tiprankstipranks
Advertisement
Advertisement

SPRO Stock Latest News

Spero Therapeutics Expands Stock Incentive Plan and Authorization
Company AnnouncementsSpero Therapeutics Expands Stock Incentive Plan and Authorization
15d ago
8K
SPRO
Spero Therapeutics secures FDA approval for Utebzi
PremiumCompany Announcements
Spero Therapeutics secures FDA approval for Utebzi
18d ago
8K
SPRO
GSK, Spero Therapeutics announce FDA approval of Utebzi
PremiumThe Fly
GSK, Spero Therapeutics announce FDA approval of Utebzi
23d ago
GSK
SPRO
Spero Therapeutics Co-Founder Resigns From Board Roles
PremiumCompany Announcements
Spero Therapeutics Co-Founder Resigns From Board Roles
5M ago
8K
SPRO
GSK Resubmits NDA, Triggering Milestone for Spero Therapeutics
PremiumCompany Announcements
GSK Resubmits NDA, Triggering Milestone for Spero Therapeutics
7M ago
8K
SPRO
Spero announces GSK filed NDA resubmission to FDA for tebipenem HBr
PremiumThe FlySpero announces GSK filed NDA resubmission to FDA for tebipenem HBr
7M ago
GSK
SPRO
Spero Therapeutics announces inducement grant under Nasdaq listing rule
Premium
The Fly
Spero Therapeutics announces inducement grant under Nasdaq listing rule
7M ago
SPRO
Spero Therapeutics Focuses on Tebipenem HBr Program
Premium
Company Announcements
Spero Therapeutics Focuses on Tebipenem HBr Program
8M ago
SPRO
Spero Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Spero Therapeutics Reports Q3 2025 Financial Results
8M ago
8K
SPRO
Spero Therapeutics, GSK announce PIVOT-PO trial efficacy and safety results
PremiumThe Fly
Spero Therapeutics, GSK announce PIVOT-PO trial efficacy and safety results
9M ago
GSK
SPRO
Spero Therapeutics’ Positive Earnings Call Highlights
PremiumCompany Announcements
Spero Therapeutics’ Positive Earnings Call Highlights
11M ago
SPRO
Spero Therapeutics Reports Q2 2025 Results and Trial Success
PremiumCompany Announcements
Spero Therapeutics Reports Q2 2025 Results and Trial Success
11M ago
SPRO
Spero Therapeutics Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsSpero Therapeutics Reports Q2 2025 Financial Results
11M ago
8K
SPRO
GSK and Spero Therapeutics Complete Promising Phase 3 Study on Oral Antibiotic for cUTI
Premium
Company Announcements
GSK and Spero Therapeutics Complete Promising Phase 3 Study on Oral Antibiotic for cUTI
1y ago
GSK
SPRO
GSK and Spero Therapeutics: Phase 3 Study Completion on Oral vs. IV UTI Treatment
Premium
Company Announcements
GSK and Spero Therapeutics: Phase 3 Study Completion on Oral vs. IV UTI Treatment
1y ago
GSK
SPRO
Spero Therapeutics Increases Stock Incentive Plan Shares
PremiumCompany Announcements
Spero Therapeutics Increases Stock Incentive Plan Shares
1y ago
8K
SPRO
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
1y ago
NNE
RKT
3 Penny Stocks to Watch Now, 5/29/25
PremiumMarket News
3 Penny Stocks to Watch Now, 5/29/25
1y ago
SGN
SPRO
Spero Therapeutics Stock (SPRO) Rockets 225% on Clinical Trial Data
PremiumMarket News
Spero Therapeutics Stock (SPRO) Rockets 225% on Clinical Trial Data
1y ago
GSK
SPRO
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
PremiumMarket NewsMorning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
1y ago
M
KO
Spero Therapeutics’ Phase 3 Trial Meets Primary Endpoint
Premium
Company Announcements
Spero Therapeutics’ Phase 3 Trial Meets Primary Endpoint
1y ago
8K
SPRO
GSK reports PIVOT-PO study for tebipenem HBr stopped early for efficacy
Premium
The Fly
GSK reports PIVOT-PO study for tebipenem HBr stopped early for efficacy
1y ago
GSK
SPRO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >